Cardiovascular complications of chemotherapy: A synopsis
It is important to identify chemotherapy-related cardiotoxicity as it may impact on the overall survival of cancer patients. The various forms of cardiotoxicity encountered during and after chemotherapy for cancer, include impaired left ventricular function leading to cardiomyopathy (CMO), myocardia...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
South African Heart Association
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0e869fe40d094656bc4768d41b83dfe7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | It is important to identify chemotherapy-related cardiotoxicity as it may impact on the overall survival of cancer patients. The various forms of cardiotoxicity encountered during and after chemotherapy for cancer, include impaired left ventricular function leading to cardiomyopathy (CMO), myocardial ischaemia, hypertension (HTN), thromboembolic states, bradycardia and prolongation of the QT interval predisposing to ventricular arrhythmias. The relationships between specific chemotherapeutic agents and the occurrence of these complications are discussed, highlighting the need for close collaboration between oncologists and cardiologists. |
|---|